Literature DB >> 1869430

Time to recurrence of squamous cell carcinoma of the head and neck.

P M Stell1.   

Abstract

A personal series of 3,215 patients with proven squamous cell carcinoma of the mucosal surfaces of the upper aerodigestive tract is presented. Of these patients, 515 suffered a recurrence of their primary tumor after a course of radiotherapy. The time from the end of radiotherapy to diagnosis of a primary recurrence was not related to any known host factors, nor to tumor factors except site. However, it was the most significant predictor of survival, both from initial presentation and from the date of recurrence. The time to recurrence did not relate to the size of the tumor at recurrence, suggesting that large recurrences are multicentric. The time to recurrence also predicted response and survival of 67 patients with end-stage disease treated by chemotherapy. The response and survival were better in tumors with a time to recurrence longer than the median; the increased survival was not significant, but the increased response was.

Entities:  

Mesh:

Year:  1991        PMID: 1869430     DOI: 10.1002/hed.2880130403

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  13 in total

1.  [Incidence, latency, and prognosis of local and regional recurrences in patients with upper aerodigestive tract cancer treated by laser microsurgery: influence of initial tumor parameters].

Authors:  M C Jäckel; A Martin; W Steiner
Journal:  HNO       Date:  2007-12       Impact factor: 1.284

2.  When is reoperative surgery not indicated for recurrent head and neck squamous cell carcinoma?

Authors:  Juan P Rodrigo; Luiz P Kowalski; Carl E Silver; Remco de Bree; Alessandra Rinaldo; Ashok R Shaha; Primož Strojan; Mohamed N Elsheikh; Missak Haigentz; Alvaro Sanabria; H Hakan Coskun; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-26       Impact factor: 2.503

3.  Relationship between the time to locoregional recurrence and survival in laryngeal squamous-cell carcinoma.

Authors:  Philippe Gorphe; Yungan Tao; Pierre Blanchard; Caroline Even; Antoine Moya-Plana; Haïtham Mirghani; France Nguyen; Stéphane Temam; François Janot
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-02-09       Impact factor: 2.503

4.  High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma.

Authors:  Sulsal Haque; Vidhya Karivedu; Muhammed K Riaz; David Choi; Logan Roof; Sarah Z Hassan; Zheng Zhu; Roman Jandarov; Vinita Takiar; Alice Tang; Trisha Wise-Draper
Journal:  Oral Oncol       Date:  2018-11-16       Impact factor: 5.337

5.  Evaluating lingual carcinoma for surgical management: what does volumetric measurement with MRI offer?

Authors:  P W Boland; S R Watt-Smith; K Pataridis; C Alvey; S J Golding
Journal:  Br J Radiol       Date:  2010-11       Impact factor: 3.039

6.  Predictors of survival in patients undergoing oropharyngeal surgery for cancer recurrence after radiation therapy.

Authors:  Molly E Heft Neal; Julia Brennan; Catherine T Haring; J Chad Brenner; Francis Worden; Paul Swiecicki; Michelle Mierzwa; Keith A Casper; Kelly M Malloy; Chaz L Stucken; Scott A McLean; Mark E Prince; Carol R Bradford; Gregory T Wolf; Andrew G Shuman; Steven B Chinn; Douglas B Chepeha; Andrew J Rosko; Matthew E Spector
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-03-19       Impact factor: 2.503

7.  Selection of Ideal Candidates for Surgical Salvage of Head and Neck Squamous Cell Carcinoma: Effect of the Charlson-Age Comorbidity Index and Oncologic Characteristics on 1-Year Survival and Hospital Course.

Authors:  JeeHong Kim; Seungwon Kim; William G Albergotti; Phillip A Choi; Daniel James Kaplan; Shira Abberbock; Jonas T Johnson; Neil Gildener-Leapman
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2015-12       Impact factor: 6.223

8.  Correlation between the duration of locoregional control and survival in T1-T2 oropharyngeal cancer patients.

Authors:  Alexandre Caula; Marc Boukhris; Joanne Guerlain; Yungan Tao; Ingrid Breuskin; Haitham Mirghani; Stéphane Temam; Philippe Gorphe
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-21       Impact factor: 2.503

9.  Deguelin induces apoptosis by targeting both EGFR-Akt and IGF1R-Akt pathways in head and neck squamous cell cancer cell lines.

Authors:  Yuh Baba; Masato Fujii; Toyonobu Maeda; Atsuko Suzuki; Satoshi Yuzawa; Yasumasa Kato
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

10.  Deguelin induces both apoptosis and autophagy in cultured head and neck squamous cell carcinoma cells.

Authors:  Yan-li Yang; Chao Ji; Zhi-gang Bi; Chun-cheng Lu; Rong Wang; Bing Gu; Lei Cheng
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.